Esther Titos

6.1k total citations
67 papers, 4.1k citations indexed

About

Esther Titos is a scholar working on Epidemiology, Biochemistry and Molecular Biology. According to data from OpenAlex, Esther Titos has authored 67 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Epidemiology, 21 papers in Biochemistry and 19 papers in Molecular Biology. Recurrent topics in Esther Titos's work include Liver Disease Diagnosis and Treatment (23 papers), Eicosanoids and Hypertension Pharmacology (17 papers) and Fatty Acid Research and Health (17 papers). Esther Titos is often cited by papers focused on Liver Disease Diagnosis and Treatment (23 papers), Eicosanoids and Hypertension Pharmacology (17 papers) and Fatty Acid Research and Health (17 papers). Esther Titos collaborates with scholars based in Spain, United States and Austria. Esther Titos's co-authors include Joan Clària, Vicente Arroyo, Cristina López‐Vicario, Ana González‐Périz, Eva Morán‐Salvador, Bibiana Rius, Marcos Martínez‐Clemente, Marta López‐Parra, Verónica García‐Alonso and Raquel Horrillo and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Immunology.

In The Last Decade

Esther Titos

64 papers receiving 4.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Esther Titos Spain 37 1.7k 1.3k 1.1k 1.1k 871 67 4.1k
Cristina López‐Vicario Spain 28 1.2k 0.7× 683 0.5× 591 0.5× 755 0.7× 568 0.7× 44 2.6k
Ana González‐Périz Spain 20 1.1k 0.6× 857 0.7× 613 0.6× 717 0.7× 602 0.7× 24 2.4k
Zhenyuan Song United States 40 1.9k 1.1× 563 0.4× 350 0.3× 1.2k 1.1× 672 0.8× 86 4.2k
Eun Ju Bae South Korea 28 1.4k 0.8× 966 0.8× 460 0.4× 1.7k 1.6× 1.4k 1.6× 80 4.7k
Maria A. Leo United States 42 2.5k 1.5× 416 0.3× 773 0.7× 1.6k 1.5× 517 0.6× 72 5.5k
Tsuguhito Ota Japan 45 3.2k 1.9× 455 0.4× 313 0.3× 2.3k 2.1× 1.7k 1.9× 86 6.8k
Shunhei Yamashina Japan 29 1.7k 1.0× 206 0.2× 356 0.3× 902 0.8× 315 0.4× 70 3.2k
Yoshiaki Tamura Japan 33 1.2k 0.7× 552 0.4× 1.1k 1.0× 2.8k 2.6× 1.4k 1.6× 94 6.0k
Iphigenia Tzameli United States 19 2.1k 1.2× 598 0.5× 275 0.3× 2.1k 1.9× 1.9k 2.2× 22 5.8k
Ion V. Deaciuc United States 28 1.5k 0.9× 197 0.2× 384 0.3× 940 0.9× 424 0.5× 96 3.2k

Countries citing papers authored by Esther Titos

Since Specialization
Citations

This map shows the geographic impact of Esther Titos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esther Titos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esther Titos more than expected).

Fields of papers citing papers by Esther Titos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Esther Titos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esther Titos. The network helps show where Esther Titos may publish in the future.

Co-authorship network of co-authors of Esther Titos

This figure shows the co-authorship network connecting the top 25 collaborators of Esther Titos. A scholar is included among the top collaborators of Esther Titos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Esther Titos. Esther Titos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
López‐Vicario, Cristina, David Sebastián, Mireia Casulleras, et al.. (2022). Essential lipid autacoids rewire mitochondrial energy efficiency in metabolic dysfunction‐associated fatty liver disease. Hepatology. 77(4). 1303–1318. 19 indexed citations
2.
Flores‐Costa, Roger, Marta Duran‐Güell, Mireia Casulleras, et al.. (2020). Stimulation of soluble guanylate cyclase exerts antiinflammatory actions in the liver through a VASP/NF-κB/NLRP3 inflammasome circuit. Proceedings of the National Academy of Sciences. 117(45). 28263–28274. 45 indexed citations
3.
Casulleras, Mireia, Roger Flores‐Costa, Marta Duran‐Güell, et al.. (2020). Albumin internalizes and inhibits endosomal TLR signaling in leukocytes from patients with decompensated cirrhosis. Science Translational Medicine. 12(566). 53 indexed citations
4.
Clària, Joan, Cristina López‐Vicario, Bibiana Rius, & Esther Titos. (2017). Pro-resolving actions of SPM in adipose tissue biology. Molecular Aspects of Medicine. 58. 83–92. 35 indexed citations
5.
García‐Alonso, Verónica, Esther Titos, José Alcaraz‐Quiles, et al.. (2016). Prostaglandin E2 Exerts Multiple Regulatory Actions on Human Obese Adipose Tissue Remodeling, Inflammation, Adaptive Thermogenesis and Lipolysis. PLoS ONE. 11(4). e0153751–e0153751. 101 indexed citations
6.
Lopategi, Aritz, Cristina López‐Vicario, José Alcaraz‐Quiles, et al.. (2015). Role of bioactive lipid mediators in obese adipose tissue inflammation and endocrine dysfunction. Molecular and Cellular Endocrinology. 419. 44–59. 61 indexed citations
7.
García‐Alonso, Verónica, Cristina López‐Vicario, Esther Titos, et al.. (2013). Coordinate Functional Regulation between Microsomal Prostaglandin E Synthase-1 (mPGES-1) and Peroxisome Proliferator-activated Receptor γ (PPARγ) in the Conversion of White-to-brown Adipocytes. Journal of Biological Chemistry. 288(39). 28230–28242. 64 indexed citations
8.
López‐Vicario, Cristina, Ana González‐Périz, Bibiana Rius, et al.. (2013). Molecular interplay between Δ5/Δ6 desaturases and long-chain fatty acids in the pathogenesis of non-alcoholic steatohepatitis. Gut. 63(2). 344–355. 112 indexed citations
9.
Titos, Esther & Joan Clària. (2013). Omega-3-derived mediators counteract obesity-induced adipose tissue inflammation. Prostaglandins & Other Lipid Mediators. 107. 77–84. 28 indexed citations
10.
Morán‐Salvador, Eva, Esther Titos, Bibiana Rius, et al.. (2013). Cell-specific PPARγ deficiency establishes anti-inflammatory and anti-fibrogenic properties for this nuclear receptor in non-parenchymal liver cells. Journal of Hepatology. 59(5). 1045–1053. 95 indexed citations
11.
Rius, Bibiana, Cristina López‐Vicario, Ana González‐Périz, et al.. (2012). Resolution of inflammation in obesity-induced liver disease. Frontiers in Immunology. 3. 257–257. 65 indexed citations
12.
Martínez‐Clemente, Marcos, Joan Clària, & Esther Titos. (2011). The 5-lipoxygenase/leukotriene pathway in obesity, insulin resistance, and fatty liver disease. Current Opinion in Clinical Nutrition & Metabolic Care. 14(4). 347–353. 53 indexed citations
13.
Horrillo, Raquel, Ana González‐Périz, Marcos Martínez‐Clemente, et al.. (2010). 5-Lipoxygenase Activating Protein Signals Adipose Tissue Inflammation and Lipid Dysfunction in Experimental Obesity. The Journal of Immunology. 184(7). 3978–3987. 129 indexed citations
14.
Martínez‐Clemente, Marcos, Natàlia Ferré, Esther Titos, et al.. (2010). Disruption of the 12/15-Lipoxygenase Gene (Alox15) Protects Hyperlipidemic Mice from Nonalcoholic Fatty Liver Disease. Hepatology. 52(6). 1980–1991. 62 indexed citations
15.
Martínez‐Clemente, Marcos, Natàlia Ferré, Ana González‐Périz, et al.. (2009). 5-Lipoxygenase Deficiency Reduces Hepatic Inflammation and Tumor Necrosis Factor α–Induced Hepatocyte Damage in Hyperlipidemia-Prone Apoe-Null Mice. Hepatology. 51(3). 817–827. 90 indexed citations
16.
López‐Parra, Marta, Esther Titos, Raquel Horrillo, et al.. (2008). Regulatory effects of arachidonate 5-lipoxygenase on hepatic microsomal TG transfer protein activity and VLDL-triglyceride and apoB secretion in obese mice. Journal of Lipid Research. 49(12). 2513–2523. 45 indexed citations
17.
Horrillo, Raquel, Anna Planagumà, Ana González‐Périz, et al.. (2007). Comparative Protection against Liver Inflammation and Fibrosis by a Selective Cyclooxygenase-2 Inhibitor and a Nonredox-Type 5-Lipoxygenase Inhibitor. Journal of Pharmacology and Experimental Therapeutics. 323(3). 778–786. 48 indexed citations
18.
López‐Parra, Marta, Joan Clària, Esther Titos, et al.. (2004). The selective cyclooxygenase-2 inhibitor celecoxib modulates the formation of vasoconstrictor eicosanoids and activates PPARγ. Influence of albumin. Journal of Hepatology. 42(1). 75–81. 17 indexed citations
19.
López‐Parra, Marta, Joan Clària, Anna Planagumà, et al.. (2002). Cyclooxygenase‐1 derived prostaglandins are involved in the maintenance of renal function in rats with cirrhosis and ascites. British Journal of Pharmacology. 135(4). 891–900. 35 indexed citations
20.
Clària, Joan, Esther Titos, Wladimiro Jiménez, et al.. (1998). Altered biosynthesis of leukotrienes and lipoxins and host defense disorders in patients with cirrhosis and ascites. Gastroenterology. 115(1). 147–156. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026